Human induced pluripotent stem cells (hiPSCs) have emerged as a transformative platform for investigating the mechanistic roles of Apolipoprotein E (APOE) isoforms in Alzheimer's Disease (AD) and other neurodegenerative conditions.
This article provides a comprehensive resource for researchers and drug development professionals on utilizing induced pluripotent stem cells (iPSCs) to model rare genetic diseases.
This article synthesizes current research on modeling tau hyperphosphorylation using human induced pluripotent stem cell (iPSC)-derived neurons, a system that recapitulates key aspects of Alzheimer's disease and related tauopathies.
This article provides a comprehensive analysis of human induced pluripotent stem cell (hiPSC) models for both familial (FAD) and sporadic (SAD) Alzheimer's disease.
This article provides a comprehensive analysis of how induced pluripotent stem cell (iPSC) models are revolutionizing Alzheimer's disease (AD) research.
This article provides a comprehensive analysis of the current efficacy and safety data from randomized clinical trials (RCTs) of stem cell therapies.
This article provides a comprehensive overview of the latest advancements in biomaterial scaffolds for stem cell delivery, a cornerstone of regenerative medicine.
This article provides a comprehensive analysis of nutritional stress challenges in implanted cells and emerging engineering solutions for biomedical researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of decellularized extracellular matrix (dECM) as a biological scaffold for stem cell-driven tissue engineering and regenerative medicine.
This article provides a comprehensive analysis of oncogenic risk assessment across diverse stem cell types, including pluripotent stem cells (PSCs), induced pluripotent stem cells (iPSCs), and adult stem cells.